1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 7, 16/Feb/2017
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

The 2016/17 mid-season vaccine effectiveness estimate against influenza A(H3N2) was 15% (95% confidence interval: −11 to 35) in Navarre. Comparing to individuals unvaccinated in the current and four prior seasons, effectiveness was 24% for current and 3–4 prior doses, 61% for current and 1–2 prior doses, 42% for only current vaccination, and 58% for 3–4 prior doses. This suggests moderate effectiveness for different combinations of vaccination in the current and prior seasons.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.7.30465
2017-02-16
2024-11-30
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.7.30465
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/7/eurosurv-22-30465-2.html?itemId=/content/10.2807/1560-7917.ES.2017.22.7.30465&mimeType=html&fmt=ahah

References

  1. European Centre for Disease prevention and Control (ECDC). Risk assessment of seasonal influenza, EU/EEA, 2016-2017 - Update, 25 January 2017. Stockholm: ECDC; 2017. Available from: http://ecdc.europa.eu/en/publications/Publications/Risk-assessment-seasonal-influenza-2016-2017-update.pdf
  2. Sistema de Vigilancia de la Gripe en España. Informe semanal de Vigilancia de la Gripe en España. Semana 5/2017 N° 494. [Weekly report of the influenza surveillance system in Spain 5/2017. No 494]. Madrid: Instituto de Salud Carlos III; 9 February 2017. Spanish. Available from: http://vgripe.isciii.es/gripe/documentos/20162017/boletines/grn052017.pdf
  3. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season. Wkly Epidemiol Rec. 2016;91(10):121-32. PMID: 26971356 
  4. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season. Wkly Epidemiol Rec. 2015;90(11):97-108. PMID: 25771542 
  5. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season. Wkly Epidemiol Rec. 2014;89(10):93-104. PMID: 24707514 
  6. Aguilar I, Reyes M, Martínez-Baz I, Guevara M, Albéniz E, Belza M, et al. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill. 2012;17(17):20154. PMID: 22551499 
  7. Castilla J, Navascués A, Fernández-Alonso M, Reina G, Albéniz E, Pozo F, et al. Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season. Euro Surveill. 2016;20(22):30243. https://doi.org/10.2807/1560-7917.ES.2016.21.22.30243  PMID: 27277013 
  8. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375-85.  https://doi.org/10.1093/cid/ciu680  PMID: 25270645 
  9. Martínez-Baz I, Casado I, Navascués A, Díaz-González J, Aguinaga A, Barrado L, et al. Effect of repeated vaccination with the same vaccine component against influenza A(H1N1)pdm09. J Infect Dis. 2017; (Forthcoming).  https://doi.org/10.1093/infdis/jix055  PMID: 28170032 
  10. Valenciano M, Ciancio BI-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):20281. PMID: 23041022 
  11. Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter A, De Serres G, et al. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveill. 2017;22(6):30460.
  12. Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2015;211(10):1519-28.  https://doi.org/10.1093/infdis/jiu650  PMID: 25416812 
  13. Thompson MG, Naleway A, Fry AM, Ball S, Spencer SM, Reynolds S, et al. Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutination inhibition antibody response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. Vaccine. 2016;34(7):981-8.  https://doi.org/10.1016/j.vaccine.2015.10.119  PMID: 26813801 
  14. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28(46):7381-8.  https://doi.org/10.1016/j.vaccine.2010.09.010  PMID: 20851086 
Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Jes%C3%BAs+Castilla&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Castilla Jesús</a>, <a href="/search?value1=Ana+Navascu%C3%A9s&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Navascués Ana</a>, <a href="/search?value1=Itziar+Casado&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Casado Itziar</a>, <a href="/search?value1=Jorge+D%C3%ADaz-Gonz%C3%A1lez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Díaz-González Jorge</a>, <a href="/search?value1=Alejandra+P%C3%A9rez-Garc%C3%ADa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pérez-García Alejandra</a>, <a href="/search?value1=Leticia+Fernandino&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fernandino Leticia</a>, <a href="/search?value1=Iv%C3%A1n+Mart%C3%ADnez-Baz&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Martínez-Baz Iván</a>, <a href="/search?value1=Aitziber+Aguinaga&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Aguinaga Aitziber</a>, <a href="/search?value1=Francisco+Pozo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pozo Francisco</a>, <a href="/search?value1=Carmen+Ezpeleta&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ezpeleta Carmen</a>, <a href="/search?value1=Primary+Health+Care+Sentinel+Network+and+the+Network+for+Influenza+Surveillance+in+Hospitals+of+Navarre&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Primary Health Care Sentinel Network and the Network for Influenza Surveillance in Hospitals of Navarre</a></span>. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(7):pii=30465. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.7.30465" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.7.30465</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 07 Feb 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Feb 2017 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.7.30465
/content/10.2807/1560-7917.ES.2017.22.7.30465
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error